25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ALVOW (Alvotech) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alvotech together

I guess you are interested in Alvotech Warrant. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Alvotech’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Alvotech’s Price Targets

I'm going to help you getting a better view of Alvotech Warrant. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alvotech Warrant

I send you an email if I find something interesting about Alvotech Warrant.

1. Quick Overview

1.1. Quick analysis of Alvotech (30 sec.)










1.2. What can you expect buying and holding a share of Alvotech? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
8.0%

What is your share worth?

Current worth
$-0.96
Expected worth in 1 year
$0.54
How sure are you?
36.0%

+ What do you gain per year?

Total Gains per Share
$1.50
Return On Investment
87.0%

For what price can you sell your share?

Current Price per Share
$1.73
Expected price per share
$1.03 - $3.69
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alvotech (5 min.)




Live pricePrice per Share (EOD)
$1.73
Intrinsic Value Per Share
$-2.16 - $-2.00
Total Value Per Share
$-3.13 - $-2.97

2.2. Growth of Alvotech (5 min.)




Is Alvotech growing?

Current yearPrevious yearGrowGrow %
How rich?-$302.2m-$682.6m$266.5m64.0%

How much money is Alvotech making?

Current yearPrevious yearGrowGrow %
Making money$24.1m-$123.5m$147.7m612.0%
Net Profit Margin15.0%243.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Alvotech (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alvotech?

Welcome investor! Alvotech's management wants to use your money to grow the business. In return you get a share of Alvotech.

First you should know what it really means to hold a share of Alvotech. And how you can make/lose money.

Speculation

The Price per Share of Alvotech is $1.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alvotech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alvotech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.96. Based on the TTM, the Book Value Change Per Share is $0.38 per quarter. Based on the YOY, the Book Value Change Per Share is $0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alvotech.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.3520.2%0.084.9%-0.46-26.6%-0.37-21.1%-0.21-12.3%-0.21-12.2%
Usd Book Value Change Per Share0.4023.3%0.3821.7%0.126.9%-0.16-9.2%0.00-0.2%-0.04-2.2%
Usd Dividend Per Share0.000.0%0.000.0%0.010.5%0.000.2%0.000.1%0.000.1%
Usd Total Gains Per Share0.4023.3%0.3821.7%0.137.3%-0.16-9.0%0.00-0.1%-0.04-2.2%
Usd Price Per Share1.51-2.56-2.24-2.00-1.20-0.96-
Price to Earnings Ratio1.08--3.89--0.47--1.88--1.13--0.90-
Price-to-Total Gains Ratio3.75-1.91--0.28-0.61-0.61-0.61-
Price to Book Ratio-1.57--1.81--0.88--1.08--0.65--0.52-
Price-to-Total Gains Ratio3.75-1.91--0.28-0.61-0.61-0.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.73
Number of shares578
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.380.00
Usd Total Gains Per Share0.380.00
Gains per Quarter (578 shares)217.40-1.26
Gains per Year (578 shares)869.62-5.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
108708604-9-15
20173917307-17-20
302609260011-26-25
403478347014-35-30
504348434018-43-35
605218521022-52-40
706087608025-61-45
806957695029-69-50
907827782032-78-55
1008696869036-86-60

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%5.020.00.020.0%5.020.00.020.0%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%9.09.02.045.0%9.010.06.036.0%9.010.06.036.0%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%2.00.023.08.0%2.00.023.08.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%9.09.02.045.0%9.010.06.036.0%9.010.06.036.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alvotech Warrant compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4030.376+7%0.119+239%-0.158+139%-0.004+101%-0.039+110%
Book Value Per Share---0.965-1.475+53%-2.563+166%-2.041+112%-0.161-83%-0.164-83%
Current Ratio--1.7261.753-2%1.027+68%1.341+29%1.388+24%1.178+47%
Debt To Asset Ratio--1.2431.357-8%1.704-27%1.541-19%1.293-4%1.148+8%
Debt To Equity Ratio----0%-0%-0%0.027-100%0.022-100%
Dividend Per Share----0%0.008-100%0.003-100%0.002-100%0.001-100%
Enterprise Value---1036014142.210-823578722.143-21%-1004013575.310-3%-916246346.372-12%-916246346.372-12%-916246346.372-12%
Eps--0.3500.085+312%-0.461+232%-0.365+204%-0.213+161%-0.211+160%
Ev To Ebitda Ratio---1.8882.888-165%2.031-193%1.231-253%1.231-253%1.231-253%
Ev To Sales Ratio---1.951-1.474-24%-23.203+1089%-12.275+529%-12.275+529%-12.275+529%
Free Cash Flow Per Share---0.035-0.199+477%-0.318+820%-0.341+887%-0.352+921%-0.301+773%
Free Cash Flow To Equity Per Share---0.053-0.057+8%-0.049-8%0.000-100%-0.015-72%-0.030-44%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%10.093-90%8.274-88%
Intrinsic Value_10Y_max---2.004----------
Intrinsic Value_10Y_min---2.161----------
Intrinsic Value_1Y_max---1.197----------
Intrinsic Value_1Y_min---1.176----------
Intrinsic Value_3Y_max---2.837----------
Intrinsic Value_3Y_min---2.724----------
Intrinsic Value_5Y_max---3.562----------
Intrinsic Value_5Y_min---3.371----------
Market Cap--473190857.790729867527.858-35%597528674.690-21%532130653.628-11%319278392.177+48%255422713.741+85%
Net Profit Margin--0.8260.150+450%2.438-66%-2.302+379%-17.110+2171%-14.842+1897%
Operating Margin--0.9710.316+207%5.931-84%0.929+5%-8.061+930%-6.839+804%
Operating Ratio--0.9200.811+13%9.357-90%5.282-83%18.035-95%13.837-93%
Pb Ratio-1.793-15%-1.565-1.813+16%-0.879-44%-1.084-31%-0.650-58%-0.520-67%
Pe Ratio1.236+13%1.079-3.893+461%-0.466+143%-1.877+274%-1.126+204%-0.901+184%
Price Per Share1.730+13%1.5102.558-41%2.243-33%2.003-25%1.202+26%0.962+57%
Price To Free Cash Flow Ratio-12.525-15%-10.932-4.940-55%-1.860-83%-2.481-77%-1.489-86%-1.191-89%
Price To Total Gains Ratio4.292+13%3.7461.915+96%-0.280+107%0.608+516%0.608+516%0.608+516%
Quick Ratio--1.0061.089-8%0.505+99%0.776+30%8.493-88%6.850-85%
Return On Assets--0.0880.021+314%-0.121+238%-0.097+211%-0.105+219%-0.098+212%
Return On Equity----0%-0%-0%-0.0350%-0.0280%
Total Gains Per Share--0.4030.376+7%0.127+218%-0.156+139%-0.002+101%-0.037+109%
Usd Book Value---302287000.000-416171750.000+38%-682677500.000+126%-523365333.333+73%-285792182.550-5%-237306176.040-21%
Usd Book Value Change Per Share--0.4030.376+7%0.119+239%-0.158+139%-0.004+101%-0.039+110%
Usd Book Value Per Share---0.965-1.475+53%-2.563+166%-2.041+112%-0.161-83%-0.164-83%
Usd Dividend Per Share----0%0.008-100%0.003-100%0.002-100%0.001-100%
Usd Enterprise Value---1036014142.210-823578722.143-21%-1004013575.310-3%-916246346.372-12%-916246346.372-12%-916246346.372-12%
Usd Eps--0.3500.085+312%-0.461+232%-0.365+204%-0.213+161%-0.211+160%
Usd Free Cash Flow---10821000.000-56162250.000+419%-84666750.000+682%-83258250.000+669%-66125051.400+511%-57626811.120+433%
Usd Free Cash Flow Per Share---0.035-0.199+477%-0.318+820%-0.341+887%-0.352+921%-0.301+773%
Usd Free Cash Flow To Equity Per Share---0.053-0.057+8%-0.049-8%0.000-100%-0.015-72%-0.030-44%
Usd Market Cap--473190857.790729867527.858-35%597528674.690-21%532130653.628-11%319278392.177+48%255422713.741+85%
Usd Price Per Share1.730+13%1.5102.558-41%2.243-33%2.003-25%1.202+26%0.962+57%
Usd Profit--109680000.00024136250.000+354%-123570000.000+213%-88849083.333+181%-52906994.600+148%-52421075.680+148%
Usd Revenue--132765000.000146402500.000-9%22000000.000+503%63671416.667+109%42606350.000+212%36027960.000+269%
Usd Total Gains Per Share--0.4030.376+7%0.127+218%-0.156+139%-0.002+101%-0.037+109%
 EOD+4 -2MRQTTM+22 -13YOY+24 -133Y+26 -115Y+25 -1410Y+24 -15

3.3 Fundamental Score

Let's check the fundamental score of Alvotech Warrant based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.236
Price to Book Ratio (EOD)Between0-1-1.793
Net Profit Margin (MRQ)Greater than00.826
Operating Margin (MRQ)Greater than00.971
Quick Ratio (MRQ)Greater than11.006
Current Ratio (MRQ)Greater than11.726
Debt to Asset Ratio (MRQ)Less than11.243
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.088
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Alvotech Warrant based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.730
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Alvotech Warrant

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Fundamental data was last updated by Penke on 2025-06-11 20:38:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Alvotech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 82.6%Β means thatΒ $0.83 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alvotech Warrant:

  • The MRQ is 82.6%. The company is making a huge profit. +2
  • The TTM is 15.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ82.6%TTM15.0%+67.6%
TTM15.0%YOY243.8%-228.8%
TTM15.0%5Y-1,711.0%+1,726.0%
5Y-1,711.0%10Y-1,484.2%-226.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Alvotech is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 8.8% Return on Assets means thatΒ Alvotech generatedΒ $0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alvotech Warrant:

  • The MRQ is 8.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.8%TTM2.1%+6.7%
TTM2.1%YOY-12.1%+14.3%
TTM2.1%5Y-10.5%+12.6%
5Y-10.5%10Y-9.8%-0.7%
4.3.1.3. Return on Equity

Shows how efficient Alvotech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Alvotech generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alvotech Warrant:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-3.5%+3.5%
5Y-3.5%10Y-2.8%-0.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alvotech Warrant.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Alvotech is operatingΒ .

  • Measures how much profit Alvotech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 97.1%Β means the company generated $0.97 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alvotech Warrant:

  • The MRQ is 97.1%. The company is operating very efficient. +2
  • The TTM is 31.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ97.1%TTM31.6%+65.5%
TTM31.6%YOY593.1%-561.5%
TTM31.6%5Y-806.1%+837.7%
5Y-806.1%10Y-683.9%-122.2%
4.3.2.2. Operating Ratio

Measures how efficient Alvotech is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.92 means that the operating costs are $0.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alvotech Warrant:

  • The MRQ is 0.920. The company is less efficient in keeping operating costs low.
  • The TTM is 0.811. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.920TTM0.811+0.109
TTM0.811YOY9.357-8.546
TTM0.8115Y18.035-17.223
5Y18.03510Y13.837+4.198
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alvotech Warrant.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alvotech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.73Β means the company has $1.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alvotech Warrant:

  • The MRQ is 1.726. The company is able to pay all its short-term debts. +1
  • The TTM is 1.753. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.726TTM1.753-0.026
TTM1.753YOY1.027+0.725
TTM1.7535Y1.388+0.364
5Y1.38810Y1.178+0.210
4.4.3.2. Quick Ratio

Measures if Alvotech is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.01Β means the company can pay off $1.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alvotech Warrant:

  • The MRQ is 1.006. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.089. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.089-0.083
TTM1.089YOY0.505+0.584
TTM1.0895Y8.493-7.404
5Y8.49310Y6.850+1.643
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alvotech Warrant.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AlvotechΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Alvotech to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.24Β means that Alvotech assets areΒ financed with 124.3% credit (debt) and the remaining percentage (100% - 124.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Alvotech Warrant:

  • The MRQ is 1.243. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.357. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.243TTM1.357-0.114
TTM1.357YOY1.704-0.348
TTM1.3575Y1.293+0.063
5Y1.29310Y1.148+0.146
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Alvotech is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alvotech Warrant:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.027-0.027
5Y0.02710Y0.022+0.005
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Alvotech generates.

  • Above 15 is considered overpriced butΒ always compareΒ Alvotech to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 1.08 means the investor is paying $1.08Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alvotech Warrant:

  • The EOD is 1.236. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.079. Based on the earnings, the company is cheap. +2
  • The TTM is -3.893. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.236MRQ1.079+0.157
MRQ1.079TTM-3.893+4.972
TTM-3.893YOY-0.466-3.427
TTM-3.8935Y-1.126-2.767
5Y-1.12610Y-0.901-0.225
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alvotech Warrant:

  • The EOD is -12.525. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.932. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.940. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.525MRQ-10.932-1.593
MRQ-10.932TTM-4.940-5.992
TTM-4.940YOY-1.860-3.080
TTM-4.9405Y-1.489-3.452
5Y-1.48910Y-1.191-0.298
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Alvotech is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -1.57 means the investor is paying $-1.57Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alvotech Warrant:

  • The EOD is -1.793. Based on the equity, the company is expensive. -2
  • The MRQ is -1.565. Based on the equity, the company is expensive. -2
  • The TTM is -1.813. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.793MRQ-1.565-0.228
MRQ-1.565TTM-1.813+0.248
TTM-1.813YOY-0.879-0.934
TTM-1.8135Y-0.650-1.163
5Y-0.65010Y-0.520-0.130
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alvotech Warrant.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Other Income Expense Net -176,748161,677-15,071-22,405-37,476-20,436-57,912140,75182,839



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,245,462
Total Liabilities1,547,749
Total Stockholder Equity-302,287
 As reported
Total Liabilities 1,547,749
Total Stockholder Equity+ -302,287
Total Assets = 1,245,462

Assets

Total Assets1,245,462
Total Current Assets458,872
Long-term Assets786,590
Total Current Assets
Cash And Cash Equivalents 38,544
Net Receivables 228,751
Inventory 142,074
Other Current Assets 49,503
Total Current Assets  (as reported)458,872
Total Current Assets  (calculated)458,872
+/-0
Long-term Assets
Property Plant Equipment 422,912
Goodwill 11,085
Intangible Assets 21,539
Long-term Assets Other 15,704
Long-term Assets  (as reported)786,590
Long-term Assets  (calculated)471,240
+/- 315,350

Liabilities & Shareholders' Equity

Total Current Liabilities265,812
Long-term Liabilities1,281,937
Total Stockholder Equity-302,287
Total Current Liabilities
Short-term Debt 43,820
Short Long Term Debt 32,752
Accounts payable 67,887
Other Current Liabilities 66,433
Total Current Liabilities  (as reported)265,812
Total Current Liabilities  (calculated)210,892
+/- 54,920
Long-term Liabilities
Long term Debt 1,063,972
Capital Lease Obligations 130,222
Long-term Liabilities  (as reported)1,281,937
Long-term Liabilities  (calculated)1,194,194
+/- 87,743
Total Stockholder Equity
Common Stock2,828
Retained Earnings -2,328,029
Accumulated Other Comprehensive Income 15,404
Other Stockholders Equity 2,007,510
Total Stockholder Equity (as reported)-302,287
Total Stockholder Equity (calculated)-302,287
+/-0
Other
Capital Stock2,828
Cash and Short Term Investments 38,544
Common Stock Shares Outstanding 313,371
Current Deferred Revenue87,004
Liabilities and Stockholders Equity 1,245,462
Net Debt 1,188,402
Net Invested Capital 794,437
Net Working Capital 193,060
Property Plant and Equipment Gross 422,912
Short Long Term Debt Total 1,226,946



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
0
118,606
118,606
118,606
251,534
251,368
251,182
251,077
597,977
250,691
774,497
683,126
895,465
895,465
910,662
958,819
950,090
1,060,637
1,068,478
1,232,948
1,221,400
1,245,462
1,245,4621,221,4001,232,9481,068,4781,060,637950,090958,819910,662895,465895,465683,126774,497250,691597,977251,077251,182251,368251,534118,606118,606118,6060000
   > Total Current Assets 
0
0
0
0
21,540
21,540
21,540
1,527
1,354
1,159
1,076
119,816
632
238,660
153,673
269,141
269,141
211,912
228,391
194,842
292,296
285,193
432,606
455,020
458,872
458,872455,020432,606285,193292,296194,842228,391211,912269,141269,141153,673238,660632119,8161,0761,1591,3541,52721,54021,54021,5400000
       Cash And Cash Equivalents 
0
0
0
0
7,922
7,922
7,922
1,278
1,087
954
919
17,556
506
128,438
12,844
115,844
115,844
60,466
68,315
11,157
64,811
10,944
118,274
51,428
38,544
38,54451,428118,27410,94464,81111,15768,31560,466115,844115,84412,844128,43850617,5569199541,0871,2787,9227,9227,9220000
       Short-term Investments 
0
0
0
0
0
0
0
0
63,378
0
0
0
35,112
0
0
0
0
0
0
0
0
0
0
0
0
00000000000035,11200063,37800000000
       Net Receivables 
0
0
0
0
9,726
9,726
9,726
9,726
13,471
13,471
13,471
53,882
17,847
38,191
51,160
46,262
46,262
49,450
42,050
87,217
72,349
155,513
145,589
251,719
228,751
228,751251,719145,589155,51372,34987,21742,05049,45046,26246,26251,16038,19117,84753,88213,47113,47113,4719,7269,7269,7269,7260000
       Other Current Assets 
0
0
0
0
1,481
1,481
1,773
499
268
410
-23,077
9,320
126
17,367
22,210
31,799
31,799
22,630
36,031
22,035
62,900
22,162
43,729
23,984
49,503
49,50323,98443,72922,16262,90022,03536,03122,63031,79931,79922,21017,3671269,320-23,0774102684991,7731,4811,4810000
   > Long-term Assets 
0
0
0
0
97,065
97,065
97,065
250,007
250,014
250,023
250,001
478,161
250,059
535,837
529,453
626,324
626,324
698,750
730,428
755,248
768,341
783,285
800,342
766,380
786,590
786,590766,380800,342783,285768,341755,248730,428698,750626,324626,324529,453535,837250,059478,161250,001250,023250,014250,00797,06597,06597,0650000
       Property Plant Equipment 
0
0
0
0
44,241
44,241
44,241
44,241
51,333
51,333
51,333
205,331
67,024
218,480
229,323
272,321
272,321
333,391
343,462
356,581
362,834
377,645
408,882
409,744
422,912
422,912409,744408,882377,645362,834356,581343,462333,391272,321272,321229,323218,48067,024205,33151,33351,33351,33344,24144,24144,24144,2410000
       Goodwill 
0
0
0
0
3,357
3,357
3,357
3,357
3,092
3,092
3,092
12,367
2,911
11,436
10,656
11,911
11,911
11,886
11,555
12,058
11,779
11,692
12,201
11,330
11,085
11,08511,33012,20111,69211,77912,05811,55511,88611,91111,91110,65611,4362,91112,3673,0923,0923,0923,3573,3573,3573,3570000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
55,307
0
51,334
47,683
48,568
47,586
43,613
42,035
18,494
18,494
0
0
0
0
000018,49418,49442,03543,61347,58648,56847,68351,334055,30700000000000
       Intangible Assets 
0
0
0
0
1,584
1,584
1,584
1,584
5,377
5,377
5,377
21,509
6,413
22,857
22,915
14,527
14,527
14,007
20,283
19,076
19,370
19,901
20,538
20,621
21,539
21,53920,62120,53819,90119,37019,07620,28314,00714,52714,52722,91522,8576,41321,5095,3775,3775,3771,5841,5841,5841,5840000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000
> Total Liabilities 
0
0
0
0
335,416
335,416
335,416
30,606
23,371
23,410
22,207
733,589
22,485
1,070,718
960,358
1,551,232
1,551,232
1,389,202
1,619,671
1,882,583
1,719,462
1,674,400
1,576,655
1,634,171
1,547,749
1,547,7491,634,1711,576,6551,674,4001,719,4621,882,5831,619,6711,389,2021,551,2321,551,232960,3581,070,71822,485733,58922,20723,41023,37130,606335,416335,416335,4160000
   > Total Current Liabilities 
0
0
0
0
12,745
12,745
12,745
382
754
1,133
3,532
111,836
6,539
277,786
202,481
160,334
160,334
221,693
186,754
260,950
246,785
1,202,466
160,549
193,396
265,812
265,812193,396160,5491,202,466246,785260,950186,754221,693160,334160,334202,481277,7866,539111,8363,5321,13375438212,74512,74512,7450000
       Short-term Debt 
0
0
0
0
626
626
626
119
119
119
119
10,066
119
128,118
83,020
28,270
28,270
30,446
22,173
47,708
48,711
1,009,680
33,801
42,217
43,820
43,82042,21733,8011,009,68048,71147,70822,17330,44628,27028,27083,020128,11811910,0661191191191196266266260000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
2,771
0
120,836
74,986
19,916
23,048
22,463
13,594
38,025
37,550
999,036
22,217
32,702
32,752
32,75232,70222,217999,03637,55038,02513,59422,46323,04819,91674,986120,83602,77100000000000
       Accounts payable 
0
0
0
0
2,990
2,990
2,990
2,990
7,147
7,147
7,147
28,587
12,297
44,726
36,441
29,766
29,766
43,931
52,662
80,563
50,175
58,566
57,720
67,126
67,887
67,88767,12657,72058,56650,17580,56352,66243,93129,76629,76636,44144,72612,29728,5877,1477,1477,1472,9902,9902,9902,9900000
       Other Current Liabilities 
0
0
0
0
5,581
5,581
5,581
-3,285
-6,512
-6,409
-4,010
35,150
-5,877
103,895
58,137
75,661
77,451
73,738
56,779
72,571
100,545
128,705
51,898
67,869
66,433
66,43367,86951,898128,705100,54572,57156,77973,73877,45175,66158,137103,895-5,87735,150-4,010-6,409-6,512-3,2855,5815,5815,5810000
   > Long-term Liabilities 
0
0
0
0
322,672
322,672
322,672
30,224
22,617
22,278
18,675
621,753
15,946
792,932
757,877
1,390,898
1,390,898
1,167,509
1,432,917
1,621,633
1,472,677
471,934
1,416,106
1,440,775
1,281,937
1,281,9371,440,7751,416,106471,9341,472,6771,621,6331,432,9171,167,5091,390,8981,390,898757,877792,93215,946621,75318,67522,27822,61730,224322,672322,672322,6720000
> Total Stockholder Equity
0
0
0
0
-216,811
-216,811
-216,811
220,928
227,997
227,772
228,870
-135,612
228,207
-296,221
-277,232
-655,767
-655,767
-478,540
-660,852
-932,493
-658,825
-605,922
-343,707
-412,771
-302,287
-302,287-412,771-343,707-605,922-658,825-932,493-660,852-478,540-655,767-655,767-277,232-296,221228,207-135,612228,870227,772227,997220,928-216,811-216,811-216,8110000
   Common Stock
0
0
0
0
18
18
18
250,001
222,998
222,772
250,001
135
250,001
2,076
2,126
2,281
2,281
2,271
2,271
2,279
2,604
2,602
2,825
2,826
2,828
2,8282,8262,8252,6022,6042,2792,2712,2712,2812,2812,1262,076250,001135250,001222,772222,998250,0011818180000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-8,494
-8,494
-8,494
-8,494
-867,243
-10,982
-10,982
4,669
-135,612
426
-4,183
36,972
36,972
35,343
41,321
41,383
36,535
34,220
16,426
15,054
15,404
15,40415,05416,42634,22036,53541,38341,32135,34336,97236,972-4,183426-135,6124,669-10,982-10,982-867,243-8,494-8,494-8,494-8,4940000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
51,422
51,422
51,422
8,494
230,199
18,409
10,982
1,000,118
135,612
1,026,282
1,058,432
1,235,274
1,235,274
1,224,814
1,224,844
1,229,690
1,726,610
1,716,605
2,007,784
2,007,058
2,007,510
2,007,5102,007,0582,007,7841,716,6051,726,6101,229,6901,224,8441,224,8141,235,2741,235,2741,058,4321,026,282135,6121,000,11810,98218,409230,1998,49451,42251,42251,4220000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue489,682
Cost of Revenue-185,309
Gross Profit304,373304,373
 
Operating Income (+$)
Gross Profit304,373
Operating Expense-234,729
Operating Income69,64469,644
 
Operating Expense (+$)
Research Development171,312
Selling General Administrative61,454
Selling And Marketing Expenses0
Operating Expense234,729232,766
 
Net Interest Income (+$)
Interest Income4,617
Interest Expense-157,601
Other Finance Cost-0
Net Interest Income-152,984
 
Pretax Income (+$)
Operating Income69,644
Net Interest Income-152,984
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-217,563356,851
EBIT - interestExpense = -217,563
-217,563
-74,263
Interest Expense157,601
Earnings Before Interest and Taxes (EBIT)-59,962-59,962
Earnings Before Interest and Taxes (EBITDA)-28,661
 
After tax Income (+$)
Income Before Tax-217,563
Tax Provision-14,301
Net Income From Continuing Ops-231,864-231,864
Net Income-231,864
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses420,038
Total Other Income/Expenses Net-287,207152,984
 

Technical Analysis of Alvotech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alvotech. The general trend of Alvotech is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alvotech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alvotech Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alvotech Warrant.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.9 < 2.98 < 3.69.

The bearish price targets are: 1.51 > 1.43 > 1.03.

Know someone who trades $ALVOW? Share this with them.πŸ‘‡

Alvotech Warrant Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alvotech Warrant. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alvotech Warrant Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alvotech Warrant.

Alvotech Warrant Daily Moving Average Convergence/Divergence (MACD) ChartAlvotech Warrant Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alvotech Warrant. The current adx is .

Alvotech Warrant Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alvotech Warrant.

Alvotech Warrant Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alvotech Warrant.

Alvotech Warrant Daily Relative Strength Index (RSI) ChartAlvotech Warrant Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alvotech Warrant.

Alvotech Warrant Daily Stochastic Oscillator ChartAlvotech Warrant Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alvotech Warrant.

Alvotech Warrant Daily Commodity Channel Index (CCI) ChartAlvotech Warrant Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alvotech Warrant.

Alvotech Warrant Daily Chande Momentum Oscillator (CMO) ChartAlvotech Warrant Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alvotech Warrant.

Alvotech Warrant Daily Williams %R ChartAlvotech Warrant Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Alvotech Warrant.

Alvotech Warrant Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alvotech Warrant.

Alvotech Warrant Daily Average True Range (ATR) ChartAlvotech Warrant Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alvotech Warrant.

Alvotech Warrant Daily On-Balance Volume (OBV) ChartAlvotech Warrant Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alvotech Warrant.

Alvotech Warrant Daily Money Flow Index (MFI) ChartAlvotech Warrant Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alvotech Warrant.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Alvotech Warrant Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alvotech Warrant based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.730
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alvotech with someone you think should read this too:
  • Are you bullish or bearish on Alvotech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alvotech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alvotech Warrant

I send you an email if I find something interesting about Alvotech Warrant.


Comments

How you think about this?

Leave a comment

Stay informed about Alvotech Warrant.

Receive notifications about Alvotech Warrant in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.